First, knowledge about how to turn on and off the ER expression in non-malignant breast epithelial cells may offer an alternative to selective oestrogen receptor modulators in prevention of breast cancer in women with elevated risk of disease47. This evidence concerns the gene ESR1 and breast cancer.